SPRWF - The Supreme Cannabis Company, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
1.1400
-0.0295 (-2.52%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close1.1695
Open1.2000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.1400 - 1.2200
52 Week Range0.8500 - 2.0400
Volume300,891
Avg. Volume317,356
Market Cap325.746M
Beta (3Y Monthly)3.04
PE Ratio (TTM)N/A
EPS (TTM)-0.0330
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Supreme Cannabis to acquire Truverra as it prepares for Legalization 2.0 and Global Medical Markets
    CNW Group2 days ago

    Supreme Cannabis to acquire Truverra as it prepares for Legalization 2.0 and Global Medical Markets

    Truverra's Health Canada licensed facility in Toronto, ON to produce cannabis derivative products for Legalization 2.0. Truverra to serve as Supreme Cannabis' global medical brand, building on existing R&D platform and established CBD offering in Europe . TORONTO , July 17, 2019 /CNW/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (FIRE.TO) (SPRWF) (53S1.F) today announced that it has entered into a definitive agreement (the "Acquisition Agreement") under which Supreme Cannabis will acquire all of the issued and outstanding shares of privately-held Truverra Inc. ("Truverra"), to be effected by way of a three-cornered amalgamation between Truverra, Supreme Cannabis and a wholly-owned subsidiary of Supreme Cannabis (the "Transaction").

  • Benzinga7 days ago

    Supreme Cannabis Closes Acquisition Of Blissco Cannabis

    Supreme Cannabis Company Inc (OTC: SPRWF ) announced that the Supreme Court of British Columbia has released a final order approving previously announced agreement to acquire Blissco Cannabis Corp. (OTC: ...

  • PR Newswire8 days ago

    Supreme Cannabis to Close Acquisition of Premium Wellness Brand and Extraction Company Blissco

    Blissco to expand Supreme Cannabis' portfolio of premium cannabis brands into the wellness category. Will provide in-house extraction capabilities for other Supreme Cannabis brands, including 7ACRES. Will expand Supreme Cannabis' product portfolio to include CBD and THC wellness products and pre-rolls.

  • GlobeNewswire10 days ago

    Blissco Cannabis Corp. Announces 99.28% Shareholder Approval of Arrangement with The Supreme Cannabis Company, Inc.

    Blissco Cannabis Corp. (the Company or Blissco) (CSE:BLIS) (HSTRF) (FRA:GQ4B) is pleased to announce that, at the special meeting of shareholders of Blissco (Blissco Shareholders) held today (the Meeting), Blissco Shareholders voted in favour of a special resolution (the Arrangement Resolution) to approve the previously announced plan of arrangement (the Arrangement) between Blissco and The Supreme Cannabis Company, Inc. (Supreme Cannabis) (FIRE.TO) (SPRWF) (53S1.F). Subject to the terms and conditions of an arrangement agreement (the Arrangement Agreement) between Blissco and Supreme Cannabis dated May 16, 2019, Supreme Cannabis will acquire all of the issued and outstanding common shares of Blissco (Blissco Shares) not already owned by Supreme Cannabis.

  • Can Vaping Growth Help Investors Extract More Value From Aphria Stock?
    InvestorPlace18 days ago

    Can Vaping Growth Help Investors Extract More Value From Aphria Stock?

    Of the multiple positive catalysts should fuel Aphria Inc (NYSE:APHA) in the months ahead, the most intriguing one is is vaping, or using a vaporizer to get the desired effect from cannabis use. My InvestorPlace colleague Will Healy pointed out some of these catalysts in his June 6 article, when APHA stock was trading at more than 50% below its 52-week high.Source: Shutterstock InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe next day, Aphria announced that it had entered into a supply agreement for the Canadian market with San Francisco-based Pax Labs, a leader in the manufacture and sale of vaporizers. In the U.S. alone, Pax has sold more than 500,000 Era vaporizers to date with plenty of growth expected in the months and years ahead. "As Aphria continues to drive the evolution of the industry, we are thrilled to partner with a technology leader like PAX to provide a new avenue for consumers to integrate cannabis into their lives," said Irwin Simon, interim CEO of Aphria. "We are excited to bring our premium cannabis extracts from Solei, RIFF and our flagship medical cannabis brand, Aphria, to the PAX Era device and platform." Vaping is Going to Be Big in CanadaThe vaping market in Canada is expected to be significant. Aphria estimates that vapes and concentrates will account for up to 30% of the entire adult-use market by 2021. The great thing about vaping, from Aphria's perspective, is that concentrates provide a much higher margin than dried cannabis. * 7 Stocks to Buy for a Dovish Fed Statistics show that U.S. use of vape products is growing, while the use of dried flower is slowing. In Colorado, the use of vape products increased tremendously over three years. In 2014, vape products accounted for 12% of the legal market. By 2017, that number had grown to 23%. Meanwhile, over the same three years, the use of dried flower dropped by 12 percentage points to 54% of the market. Between edibles, concentrates, and infused drinks, the cannabis industry is moving away from the dried flower to an industry filled with choice. The fact that Aphria is partnering with one of the premier vape companies is a sign that Simon understands the importance of moving beyond supplying dried buds. APHA Is Not AloneThat only downside from Aphria's announcement is that PAX pick three other Canadian cannabis producers to help sell its product: Aurora Cannabis (NYSE:ACB), OrganiGram (NASDAQ:OGI), and Supreme Cannabis (OTCMKTS:SPRWF). However, the fact that Aphria is near completion of it $55 million Extraction Centre of Excellence in Leamington, Ontario, makes this concern far less of an issue. That's because when completed, Aphria will have annual extraction capacity of 200,240 kilograms, making it one of the largest extractors in Canada. Currently, analysts haven't factored Aphria's extraction facility into their valuation models. Once the facility is running, and products are available for sale in late December or early in 2020, Aphria stock is going to be far more attractive to investors than it is today. Bottom Line on Aphria StockIn May, I highlighted the pros and cons of the regime change at Aphria. As I stated, it's hard to know if Irwin Simon's the right person for the job. While his work at Hain Celestial (NASDAQ:HAIN) was at times exceptional, in recent years he did little to impress investors, eventually stepping down as CEO in June 2018. * The Top 8 Tech Stocks of 2019 (So Far) Joining the Aphria Inc board in December as chairman, Simon was appointed interim CEO on March 1 after former boss Vic Neufeld retired in January. Since then, Simon's made a few management changes to put his own stamp on the company. The PAX announcement is a sign Simon might be sticking around as the permanent CEO. If the board didn't have confidence in him, this kind of deal probably wouldn't have happened. While not completely sold on Simon, the PAX deal in combination with the completion of the extraction plant, suggests investors aren't giving Aphria stock its due.Aggressive investors ought to consider buying this potential growth and value play. At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * The 7 Top Small-Cap Stocks Of 2019 * Critical Levels to Watch in 7 Marijuana Stocks * 5 Smaller Cloud Stocks That Have Plenty of Potential Compare Brokers The post Can Vaping Growth Help Investors Extract More Value From Aphria Stock? appeared first on InvestorPlace.

  • Benzinga24 days ago

    Supreme Cannabis, Wiz Khalifa's Kush Enterprises Canada Launch Cannabis Oil

    Supreme Cannabis Company Inc (OTC: SPRWF) on Tuesday launched a premium cannabis oil in partnership with Khalifa Kush Enterprises Canada. The KKE Oil is the first product under the KKA brand line developed under the partnership between Supreme Cannabis Company and rapper Wiz Khalifa's Khalifa Kush Enterprises Canada. It uses Sensi Star strain developed by 7ACRES, a wholly-owned subsidiary of Supreme Cannabis.

  • Supreme Cannabis Launches Premium Cannabis Oil in Partnership with Wiz Khalifa and Khalifa Kush Enterprises Canada
    PR Newswire24 days ago

    Supreme Cannabis Launches Premium Cannabis Oil in Partnership with Wiz Khalifa and Khalifa Kush Enterprises Canada

    KKE Oils were created for recreational consumers who want the convenience, high THC potency and precise dosing offered with a cannabis oil. KKE Oils are the first in a full suite of recreational focused products to be created under the partnership between Supreme Cannabis, Wiz Khalifa and Khalifa Kush Enterprises Canada. KKE Oils are expected to be available in British Columbia and Ontario by the end of the week and Alberta in early July 2019.

  • PR Newswire25 days ago

    /R E P E A T -- Supreme Cannabis to Launch Investment Platform Supreme Heights/

    TORONTO, June 24, 2019 /PRNewswire/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (FIRE.TO) (SPRWF) (53S1.F), today announced the launch of Supreme Heights, an investment platform based in London, UK focused on opportunities in the UK and Europe's CBD health and wellness space. Supreme Heights intends to make strategic investments in and provide support services to differentiated high-growth health and wellness businesses with focused brands and premium CBD offerings.

  • PR Newswire25 days ago

    Supreme Cannabis to Launch Investment Platform Supreme Heights

    TORONTO, June 24, 2019 /PRNewswire/ -- The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (FIRE.TO) (SPRWF) (53S1.F), today announced the launch of Supreme Heights, an investment platform based in London, UK focused on opportunities in the UK and Europe's CBD health and wellness space. Supreme Heights intends to make strategic investments in and provide support services to differentiated high-growth health and wellness businesses with focused brands and premium CBD offerings.

  • 4 Top Marijuana Penny Stocks to Take Seriously in 2019
    InvestorPlacelast month

    4 Top Marijuana Penny Stocks to Take Seriously in 2019

    [Editor's Note: This story was previously published in February 2019. It has since been updated and republished.]The 2018 midterm elections made clear that Americans preferred legalization over the continued prohibition of pot, which should bolster the case for the top marijuana penny stocks.When residents in California voted for full recreational weed, it boded well not just for marijuana penny stocks, but for electoral momentum in other states and the midterms emphatically proved this point.InvestorPlace - Stock Market News, Stock Advice & Trading TipsIn conservative Utah and Missouri, voters approved medical cannabis. But Michigan stood above the rest, becoming the tenth state to legalize recreational marijuana. Significantly, it's also the first Midwestern state to approve such an initiative.Previously embattled marijuana stocks like Cronos Group (NASDAQ:CRON), Aurora Cannabis (NYSE:ACB) and Canopy Growth (NYSE:CGC) received a much-needed boost in the markets and really have capitalized on it.It's not difficult to understand why many investors believe in weed. Not only does legal marijuana open doors to a previously inaccessible sector, it has proven economic benefits. The commonly cited case study is Colorado. In 2015, one year after green lighting cannabis businesses, the botanical industry nearly hit $1 billion in revenue. In 2016, it breached the threshold, and growth remains strong. Considering that so many states suffer from budget shortfalls, a little green could go a long way.Plus, the sharp war of words and tariffs in U.S.-China trade relations amps up the case for marijuana penny stocks. Multiple industries, especially agriculture, are hurting. Full legalization provides an easy catalyst for economic activity and growth. * 7 High-Quality Cheap Stocks to Buy With $10 Under this backdrop, gambling on top marijuana penny stocks is more compelling than jumping on any other speculative venture. While risks abound, these four sector players offer considerable upside possibilities. Auxly Cannabis Group (CBWTF)A common difficulty in forecasting future price movements for top marijuana penny stocks is separating hype from reality. While almost every sector player advertises significant upside potential, most undercapitalized firms fail to deliver the goods.I had high hopes for Auxly Cannabis (OTCMKTS:CBWTF) last year due to its unique business structure. Auxly earned bragging rights for becoming the first cannabis streaming company.Energy and mining companies typically deploy the streaming model to gain full access to an industry's supply chain without incurring unnecessary risk. In theory, streaming is the way to go for marijuana-related organizations. Even with Canada's legalization initiative and U.S. electoral momentum, several legal and administrative hurdles exist. Streaming facilitates exposure to a lucrative industry, but with "stop gaps" should things go awry.Unfortunately, the markets have not been kind to Auxly stock. Since its January opener, shares have lost more than half their equity value.Nevertheless, I'm still hopeful that Auxly can pull it together. One of the major challenges for the company is that its streaming partners still encounter arguably unreasonable non-cannabis related obstacles. The biggest on the list is securing traditional financing, which stymies expansion efforts.However, the cannabis industry is making steady steps toward mainstream institutional acceptance. And especially with the U.S.-China trade war heating up, even conservative administrations can't afford overlooking a key revenue-maker. MPX Bioceutical (MPXEF)A common stereotype about legal-cannabis advocates is that they have ulterior motives for their product evangelism. Although that could be the case, one thing is undeniable: many, if not most top marijuana penny stocks focus on botany's medicinal aspect.This is especially true for MPX International (OTCMKTS:MPXOF). MPX operates three brands under its corporate umbrella: Salus BioPharma, Health for Life and its namesake MPX.The former two divisions specialize in medical-grade cannabis, while the latter caters to the green lifestyle. Salus is particularly intriguing as it represents a joint venture with Israeli pharmaceutical Panaxia to develop proprietary, smokeless cannabis products.Another compelling driver for MPXOF stock is its recent partnership with South Africa's First Growth Holdings. Primarily, this is an attractive deal because South Africa provides ample land and inexpensive labor. Moreover, the country recently legalized weed, so it provides MPX with global revenue synergies. Granted, management must make investments to ensure the higher-quality inventory which western connoisseurs desire. Nevertheless, the cost outlay should be very reasonable compared to other locales. * 7 Top-Rated Biotech Stocks to Invest In Today That's not to say you should jump on MPXOF stock without worries. The company isn't what you would consider fundamentally sound. Still, with relatively stable market performance and an impressive growth rate, speculators will want to keep close tabs on MPX. Supreme Cannabis Company (SPRWF)When Canada became the first G7 nation to approve recreational weed in October 2018, it actually forged the path forward for marijuana startups. As a result, the lion's share of marijuana penny stocks is based in Canada.A prime example is Supreme Cannabis Company (OTCMKTS:SPRWF). Supreme Cannabis, whose 7ACRES brand of medical-grade cannabis started life as a father seeking alternative therapies for his daughter.Eventually, 7ACRES grew to become a gold-standard cannabis facility, offering distinct, high-quality strains.What makes SPRWF stand out compared to other top marijuana penny stocks is that management is focused on a business-to-business (B2B) strategy. This enables the company to fine-tune its craft, rather than dilute its effectiveness through disparate supply-chain segments.Over the long run, I think this higher-end focus will distinguish SPRWF stock from the competition. For example, several mainstream retail stores, including Neiman Marcus and Vitamin Shoppe (NYSE:VSI), have pushed for cannabidiol, or CBD, products.Obviously, that's a big plus for the broader marijuana industry. But just selling bottom-shelf weed at large volume isn't going to cut it. Consumers want differentiation, which is what Supreme Cannabis offers. Therefore, SPRWF stock has a chance to positively surprise.That said, this is a very volatile market. SPRWF stock is a high-risk, high-reward venture, but a very tempting one due to positive industry-related developments. Cannabis Science (CBIS)Cannabis Science (OTCMKTS:CBIS) is easily one of the most speculative among top marijuana penny stocks. Immediately, you can tell that through either its ridiculously low share price, or its sub-$100 million market capitalization.Another giveaway is Cannabis Science's bold declaration to provide innovative therapies for unmet medical needs, including cancer. As the old saying goes, extraordinary claims require extraordinary evidence.But this is also where CBIS stock becomes interesting. Management claims that cannabis use dates back thousands of years, making it one of the most tried-and-true medicines. Plus, traditional pharmaceutical companies have become more a marketing machine than a therapy provider. Therefore, the medical-cannabis industry deserves at least some credibility.Also, I think it's fair to point out that the opioid crisis has caused mainstream pharmaceuticals to lose credibility. Despite best intentions, the pharmaceutical industry has left a wave of problems in its wake. This could negatively impact generations of Americans. Thus, marijuana penny stocks related to medical cannabis could benefit.That's the good news for CBIS stock. The not so great news is that shares continue to struggle. * 7 U.S. Stocks to Buy With Limited Trade War Exposure Conservative investors should probably stay away from Cannabis Science and marijuana penny stocks in general. But if you're a speculator, CBIS stock appears to have bottomed after a recent bout of volatility. It's no guarantee of upside, but it might be worth a shot with gambling money.As of this writing, Josh Enomoto did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 5 Red-Hot IPO Stocks to Buy for the Long Run * 5 Stocks to Buy for $20 or Less * 4 Dow Jones Stocks Ready to Rise Compare Brokers The post 4 Top Marijuana Penny Stocks to Take Seriously in 2019 appeared first on InvestorPlace.

  • PR Newswirelast month

    Supreme Cannabis Well-Positioned for Health Canada's Final Regulations for New Cannabis Products

    TORONTO, June 18, 2019 /PRNewswire/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (FIRE.TO) (SPRWF) (53S1.F) welcome's Health Canada's final regulations for new cannabis products ("Health Canada's Regulations") and reiterates its expanded product strategy. On June 14, 2019, Health Canada released to license holders amended cannabis regulations to permit the legal production and sale of three additional types of cannabis products, including, cannabis edibles, extracts and topicals.

  • PR Newswirelast month

    Supreme Cannabis Announces Exclusive Partnership with PAX Labs

    Supreme Cannabis becomes one of only four initial supply partners for the PAX Era. 7ACRES-branded vaporizer oil will be sold exclusively in Era-compatible pods. Partnership will accelerate Supreme Cannabis' growth into the anticipated vaporizer market.

  • OTC Markets Group Launches OTCQX Cannabis Index
    PR Newswirelast month

    OTC Markets Group Launches OTCQX Cannabis Index

    NEW YORK , June 4, 2019 /PRNewswire/ --  OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Cannabis Index ...

  • PR Newswire2 months ago

    Supreme Cannabis Announces June Speaking Engagements

    TORONTO , June 3, 2019 /PRNewswire/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), is pleased to announce the Company's ...

  • CNW Group2 months ago

    Supreme Cannabis Welcomes New CBD Legislation in South Africa

    Supreme Cannabis' international medical cannabis oil partner, Medigrow Lesotho ("Medigrow"), is licensed by the Lesotho Ministry of Health to cultivate and manufacture medical cannabis and cannabis oil products in the Kingdom of Lesotho , a jurisdiction located within Southern Africa . Supreme Cannabis will explore opportunities to serve South Africa's commercial CBD market through its preferential global distribution agreement with Medigrow.

  • GlobeNewswire2 months ago

    Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of BlissCo Cannabis Corp. (Other OTC: HSTRF) on Behalf of BlissCo Shareholders and Encourages BlissCo Investors to Contact the Firm

    NEW YORK, May 21, 2019 -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of BlissCo Cannabis Corp. (Other OTC: HSTRF) on.